Targeted Cancer Cell Killing by Highly Selective miRNA-Triggered Activation of a Prokaryotic Toxin-Antitoxin System

Area of Science:

• Molecular Biology
• Synthetic Biology
• Cancer Research

Background:

• Prokaryotic toxin Kid induces apoptosis in human cells, neutralized by antitoxin Kis.
• Previous work engineered a synthetic toxin-antitoxin system targeting viral oncoprotein E6 for cancer cell killing.
• Need exists to broaden the range of oncogenic insults and cancer types targeted by such systems.

Purpose of the Study:

• To develop a synthetic toxin-antitoxin system targeting microRNA overexpression in cancer cells.
• To broaden the applicability of synthetic toxin-antitoxin systems for cancer therapy.

Main Methods:

• Engineered a synthetic toxin-antitoxin pair by linking the *kis* gene to a microRNA target site.
• Tested the system's selectivity in cancer cells overexpressing specific microRNAs.
• Evaluated the system's safety in non-targeted cells, including those with homologous microRNAs.

Main Results:

• Successfully constructed a synthetic toxin-antitoxin system responsive to oncogenic human microRNAs.
• Demonstrated selective killing of cancer cells overexpressing the targeted microRNA.
• Showed that non-targeted cells, even with homologous microRNAs, were spared from collateral damage.

Conclusions:

• Synthetic toxin-antitoxin systems can be engineered to target cancer cells based on microRNA expression profiles.
• This approach offers high selectivity, sparing normal cells and reducing off-target effects.
• The findings expand the potential of synthetic biology for developing targeted cancer therapeutics.